Document Detail


The necessity and reliability of intraoperative parathyroid hormone (PTH) testing in patients with mild hyperparathyroidism and PTH levels in the normal range.
MedLine Citation:
PMID:  21713573     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Intraoperative parathyroid hormone (IoPTH) testing is useful in the management of hyperparathyroidism. The successful removal of hypersecreting parathyroids is indicated by a decrease in PTH levels >50% within 15 min. A subset of patients with mild hyperparathyroidism will actually have starting PTH levels in the normal range. We sought to determine if IoPTH testing is necessary in these patients and if the 50% rule delineating surgical cure is reliable.
METHODS: A retrospective review was performed on all patients who underwent parathyroidectomy for hyperparathyroidism at a single institution from 3/2001 to 8/2008.
RESULTS: Of the 1,001 patients, 142 (14%) had mild hyperparathyroidism and normal baseline PTH levels (<65 pg/ml). Their mean PTH was 59 ± 1 pg/ml. During surgery, 105 (74%) had a >50% decline in PTH levels after resection of hyperfunctioning parathyroid glands, and their operations were terminated. In contrast, 37 (26%) patients did not have a >50% decline in PTH levels leading to further surgical exploration. In these 37 patients, the PTH levels fell by >50% after the removal of the additional glands in 25 patients (17.6%) and dropped after 20 min in 7 patients (4.9%). In 5 patients (3.5%) the IoPTH did not drop. Of the 142 total patients, 91 had single adenomas and 51 patients had multi-gland disease. All patients (100%) were cured (normal serum calcium after 6 months).
CONCLUSIONS: Intraoperative PTH testing plays an important role in the operative management in 14% of patients with mild hyperparathyroidism. Importantly, a 50% decline in IoPTH level within 15 min of parathyroidectomy is 96.5% reliable in predicting cure in these patients with PTH starting in the normal range.
Authors:
Amal Alhefdhi; Scott N Pinchot; Ruth Davis; Rebecca S Sippel; Herbert Chen
Related Documents :
2861613 - Pharmacologic approaches to obstructive airway disease.
19205703 - Airway malacia in chronic obstructive pulmonary disease: prevalence, morphology and rel...
12943893 - Usefulness of anemia as a predictor of death and rehospitalization in patients with dec...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  World journal of surgery     Volume:  35     ISSN:  1432-2323     ISO Abbreviation:  World J Surg     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-09     Completed Date:  2011-12-23     Revised Date:  2012-02-14    
Medline Journal Info:
Nlm Unique ID:  7704052     Medline TA:  World J Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2006-9     Citation Subset:  IM    
Affiliation:
Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, H4/722 CSC 600 Highland Avenue, Madison, WI 53792, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cohort Studies
Female
Humans
Hyperparathyroidism / blood*,  diagnosis,  surgery*
Male
Middle Aged
Monitoring, Intraoperative / methods*
Parathyroid Hormone / blood*
Parathyroidectomy / adverse effects,  methods*
Postoperative Care / methods
Reference Values
Reproducibility of Results
Retrospective Studies
Risk Assessment
Severity of Illness Index
Treatment Outcome
Chemical
Reg. No./Substance:
0/Parathyroid Hormone
Comments/Corrections
Comment In:
World J Surg. 2012 Feb;36(2):483; author reply 484-5   [PMID:  21947460 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pullulan production by Aureobasidium pullulans cells immobilized in chitosan beads : Fungal pullulan...
Next Document:  Planned Hernia Repair and Late Abdominal Wall Reconstruction.